J&J starts SKYWARD study of carotid IVL system

J&J has begun enrolment in its SKYWARD IDE clinical programme to evaluate the Shockwave SkyRunner Carotid IVL system. The SKYWARD programme includes two planned prospective, multi-centre, single-arm IDE studies. Accounting for up to 30% of strokes, carotid artery disease is characterised by plaque build-up in the arteries supplying the brain. Credit: Mehmet Cetin / Shutterstock.com. Johnson & Johnson (J&J) has initiated enrolment in its SKYWARD investigational device exemption (IDE) clinical programme to evaluate the Shockwave SkyRunner Carotid intravascular lithotripsy (IVL) system. The initiative aims to treat calcified carotid arteries before stenting. The first participant was treated at McLaren Bay Region…

Source: Medical Device Network